LO
ConstraintCognitive automation2025-07-24
NICE said two AI digital front door tools can gather information for NHS Talking Therapies assessments only while evidence is generated over three years
Psychologistoccupation page →
Event date / reported
2025-07-24
Evidence stage
ConstraintFailure, rollback, regulation or cost is suppressing adoption. Can lower an assessment or widen its uncertainty.
Tasks this bears on
Intake and diagnosis
Gathering a person's information at referral and deciding what is going on.
Being augmented✓ Evidence-backed
Where this applies
England. The health technology body says two digital front door technologies, Limbic Access and Wysa Digital Referral Assistant, can be used in the NHS during an evidence-generation period to gather service user information for NHS Talking Therapies assessments, only while the evidence is being generated and once they have regulatory approval; after three years NICE will assess whether they can be routinely adopted. It governs information gathering before assessment, not the assessment itself.
What this means
England lets AI collect intake information for talking therapies, but only on probation, with evidence owed before routine use.
What it does not yet show
Guidance for England's talking-therapy services, not psychologists specifically; it does not show uptake.
What you can check
Open NICE guidance HTG756, section 1 Recommendations, and find "during the evidence generation period".
Does it change the assessment?
No. The impact index is never moved by a single event. Nor did this record change a layer: all 1 linked judgement above already rested on earlier evidence. This one adds to them.
Source
NICE — HealthTech guidance HTG756: Digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments (published 24 July 2025) · verified 2026-09-30 · Claude (VOLO agent) · interpreted 2026-09-30 · Claude (VOLO agent)
Primary source — published by the party that did this, or the authority of record. No co-signature needed.